Search - tctmd.com

Displaying 821 - 840 of 1082

Sort: Relevancy | Date

News Industry News

The Medicines Company and Alnylam Announce Presentation of New Pre-Clinical Data on PCSK9 at Arteriosclerosis, Thrombosis and Vascular Biology 2014 Scientific Sessions

May 01, 2014

News Industry News

InspireMD Announces Voluntary Field Action for MGuard™ Prime EPS

April 30, 2014

News Industry News

Edwards Lifesciences Launches Philanthropic Initiative to Impact Global Burden of Heart Valve Disease

April 28, 2014

News Conference News ACC 2014

CHOICE Trial, TVT Registry Shed Light on Evolving TAVR Outcomes, Risks

L.A. McKeown

March 31, 2014

News Conference News ACC 2014

TAVR With the CoreValve Device Superior to Surgery at 1 Year

Yael L. Maxwell

March 29, 2014

News Daily News

Elderly ACS Patients Receive Less Intensive Treatment, Survival Benefit Reduced

Caitlin E. Cox

March 27, 2014

News Industry News

eCardio to Highlight EMR Integration Expertise for Remote Monitoring Customers at Upcoming Conferences

March 26, 2014

News Daily News

CoreValve Reduces Mortality at 1 Year in Patients at Extreme Surgical Risk

March 20, 2014

News Daily News

CoreValve Reduce la Mortalidad al cabo de 1 Año en Pacientes de Riesgo Quirúrgico Extremo

March 20, 2014

News Daily News

研究质疑TAVR改善心理及总体健康状况的能力

L.A. McKeown

March 13, 2014

News Daily News

Study Questions Ability of TAVR to Improve Psychological, General Health

L.A. McKeown

March 13, 2014

News Industry News

Corindus Vascular Robotics, Sanford Health and The Leona M. and Harry B. Helmsley Charitable Trust Launch Remote Robotics Program

March 11, 2014

News Daily News

La EPOC es Común en Pacientes TAVR y se Asocia a una Mayor Mortalidad CV

Jason Kahn

March 06, 2014

News Daily News

COPD Common in TAVR Patients, Associated with Increased CV Mortality

Jason Kahn

March 06, 2014

News Daily News

Over the Long Haul, TAVR Appears Better Than Surgery for Women

Caitlin E. Cox

February 19, 2014

News Daily News

A la Larga, la TAVR parece Mejor que la Cirugía en Mujeres

Caitlin E. Cox

February 19, 2014

News Industry News

Edwards' SAPIEN XT Valve Approved in Europe for Transcatheter Mitral and Aortic Valve-in-Valve Procedures

February 04, 2014

News Industry News

Medtronic CoreValve® System Obtains Early FDA Approval

January 16, 2014

News Industry News

ARIAD and Medinol Announce Initiation of Two Registration Trials of the NIRsupreme™ Ridaforolimus-Eluting Stent for Use in Coronary Artery Disease

January 13, 2014

News Daily News

TAVR早期结果与PARTNER研究结果相似，但并发症更少

Jason Kahn

January 01, 2014

Advertisement

The Medicines Company and Alnylam Announce Presentation of New Pre-Clinical Data on PCSK9 at Arteriosclerosis, Thrombosis and Vascular Biology 2014 Scientific Sessions

InspireMD Announces Voluntary Field Action for MGuard™ Prime EPS

Edwards Lifesciences Launches Philanthropic Initiative to Impact Global Burden of Heart Valve Disease

CHOICE Trial, TVT Registry Shed Light on Evolving TAVR Outcomes, Risks

TAVR With the CoreValve Device Superior to Surgery at 1 Year

Elderly ACS Patients Receive Less Intensive Treatment, Survival Benefit Reduced

eCardio to Highlight EMR Integration Expertise for Remote Monitoring Customers at Upcoming Conferences

CoreValve Reduces Mortality at 1 Year in Patients at Extreme Surgical Risk

CoreValve Reduce la Mortalidad al cabo de 1 Año en Pacientes de Riesgo Quirúrgico Extremo

研究质疑TAVR改善心理及总体健康状况的能力

Study Questions Ability of TAVR to Improve Psychological, General Health

Corindus Vascular Robotics, Sanford Health and The Leona M. and Harry B. Helmsley Charitable Trust Launch Remote Robotics Program

La EPOC es Común en Pacientes TAVR y se Asocia a una Mayor Mortalidad CV

COPD Common in TAVR Patients, Associated with Increased CV Mortality

Over the Long Haul, TAVR Appears Better Than Surgery for Women

A la Larga, la TAVR parece Mejor que la Cirugía en Mujeres

Edwards' SAPIEN XT Valve Approved in Europe for Transcatheter Mitral and Aortic Valve-in-Valve Procedures

Medtronic CoreValve® System Obtains Early FDA Approval

ARIAD and Medinol Announce Initiation of Two Registration Trials of the NIRsupreme™ Ridaforolimus-Eluting Stent for Use in Coronary Artery Disease

TAVR早期结果与PARTNER研究结果相似，但并发症更少

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content